We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+1.12%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$327M
AUM Growth
-$12.2M
Cap. Flow
-$9.88M
Cap. Flow %
-3.02%
Top 10 Hldgs %
48.42%
Holding
1,378
New
400
Increased
269
Reduced
149
Closed
483

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$19M
2
CELG
Celgene Corp
CELG
+$18.7M
3
SPCE icon
Virgin Galactic
SPCE
+$10.7M
4
WBC
WABCO HOLDINGS INC.
WBC
+$9.32M
5
GWR
Genesee & Wyoming Inc.
GWR
+$7.4M

Top Sells

Rank Stock Value
1
APC
Anadarko Petroleum
APC
+$49M
2
RHT
Red Hat Inc
RHT
+$47.6M
3
FDC
First Data Corporation
FDC
+$7.23M
4
MLNX
Mellanox Technologies, Ltd.
MLNX
+$4.11M
5
ARRY
Array Biopharma Inc
ARRY
+$3.62M

Sector Composition

Rank Sector Weight
1 Healthcare 30.14%
2 Financials 12.64%
3 Industrials 9.02%
4 Consumer Discretionary 7.86%
5 Technology 6.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVGO icon
851
Broadcom
AVGO
$1.99T
– –
-1,790
Closed -$51K
AVTR icon
852
Avantor
AVTR
$9.37B
– –
-600
Closed -$11K
AXON
853
Axon Enterprise
AXON
$50B
– –
-29,056
Closed -$1.86M
AXTA icon
854
CALL
Axalta
AXTA
$7.93B
– –
-100
Closed -$2K
BAC icon
855
Bank of America
BAC
$448B
– –
-15
Closed –
BBAR icon
856
BBVA Argentina
BBAR
$3.27B
$0 ﹤0.01%
109
+100
+1,111% +$778
BBIO icon
857
BridgeBio Pharma
BBIO
$15.9B
– –
-256
Closed -$6K
BCO icon
858
Brink's
BCO
$4.72B
– –
-2,500
Closed -$202K
BELFA icon
859
Bel Fuse Inc Class A
BELFA
$3.4B
$0 ﹤0.01%
15
-515
-97% -$6.62K
BF.B icon
860
Brown-Forman Class B
BF.B
$12.9B
– –
-498
Closed -$27K
BGC icon
861
BGC Group
BGC
$5.2B
– –
-3,066
Closed -$16K
BGS icon
862
B&G Foods
BGS
$299M
– –
-689
Closed -$14K
BIIB icon
863
CALL
Biogen
BIIB
$31.1B
– –
-9
Closed -$2K
BMA icon
864
Banco Macro
BMA
$5.14B
– –
-92
Closed -$6K
BMRC icon
865
Bank of Marin Bancorp
BMRC
$462M
– –
-13,434
Closed -$551K
BOC icon
866
Boston Omaha
BOC
$431M
– –
-617
Closed -$14K
BSX icon
867
Boston Scientific
BSX
$74.9B
– –
-100
Closed -$4K
BTO
868
John Hancock Financial Opportunities Fund
BTO
$819M
– –
-4,033
Closed -$129K
BTOG icon
869
Bit Origin
BTOG
$3.48M
– –
0
– –
BBBY
870
CALL
Bed Bath & Beyond
BBBY
$423M
– –
-466
Closed -$4K
BBBY
871
Bed Bath & Beyond
BBBY
$423M
– –
-23,865
Closed -$243K
CACI icon
872
CACI
CACI
$14.8B
– –
-390
Closed -$79K
CAKE icon
873
PUT
Cheesecake Factory
CAKE
$5.57B
– –
-100
Closed -$4K
CARM
874
DELISTED
Carisma Therapeutics
CARM
– –
-1,250
Closed -$37K
CAT icon
875
Caterpillar
CAT
$393B
– –
-1,250
Closed -$170K
33 34
35
36 37

Similar funds

ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
BCH
Berkshire Capital Holdings San Jose, California $277M AUM 190.28% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
HCM
Hall Capital Management Barrington, Rhode Island $280M AUM 14.82% 1-Year Est. Return
EFP
Envision Financial Planning Memphis, Tennessee $276M AUM 10.87% 1-Year Est. Return

FNY Investment Advisers's Q3 2019 Portfolio in Review

As of Q3 2019, FNY Investment Advisers held 1,378 positions worth $327M, down 3.6% from $339M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

FNY Investment Advisers withdrew a net $9.88M in Q3 2019, closing 483 positions and reducing 149 holdings. Its most notable exit was Anadarko Petroleum, an estimated $49M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.

Against the trend, FNY Investment Advisers opened a new position in Genesee & Wyoming Inc. worth $7.43M.

  • FNY Investment Advisers's largest Q3 2019 buy was Genesee & Wyoming Inc.: 67,241 shares worth $7.43M.
  • FNY Investment Advisers added most to Allergan plc in Q3 2019, an estimated $19M increase.
  • FNY Investment Advisers's biggest Q3 2019 reduction was Mellanox Technologies, Ltd., cutting an estimated $4.11M.
  • FNY Investment Advisers fully exited Anadarko Petroleum in Q3 2019, selling an estimated $49M.
  • FNY Investment Advisers's ten largest holdings make up 48% of its $327M portfolio in Q3 2019.
  • FNY Investment Advisers opened 400 new positions and closed 483 in Q3 2019.
  • FNY Investment Advisers's portfolio value fell 3.6% quarter-over-quarter to $327M.

Based on FNY Investment Advisers's 13F filing for Q3 2019, filed 25 Oct 2019.